Finanznachrichten

United States Food and Drug Administration (USFDA) - BioResearch Monitoring Program (BIMO) Conducted 2 Inspections at Veeda CR - Ahmedabad

Veeda Clinical Research is glad to share the successful completion of 2 USFDA Inspections at 2 of its locations at Ahmedabad in Sep-2017. Both the Inspections were Routine Inspections by BIMO ...
RAPS

FDA Makes Changes to Bioresearch Monitoring Information System

The US Food and Drug Administration (FDA) released new updates to the Bioresearch Monitoring Information System (BMIS) on 9 January.  The program is used by FDA to oversee regulated clinical ...
BioWorld

FDA declines to clarify on-site access restrictions in BiMo final

The U.S. FDA’s final guidance for clinical trial inspections conducted under the bioresearch monitoring (BiMo) program seems to deviate little if at all from the 2024 draft, but that is precisely the ...
Healthline

FDA Oversight of Clinical Trials was 'Grossly Inadequate,' Report Claims

The FDA is responsible for reviewing data on vaccines, drugs, and medical devices, and deciding whether these products should be approved for use in the United States. A new report in the medical ...
BioWorld

US FDA struggling to keep up with clinical research inspections

The lingering effects of the COVID-19 pandemic and ongoing recruitment/retention issues are making it difficult for the U.S. FDA’s bioresearch monitoring program to keep up with the on-site clinical ...
PR Newswire

United States Food and Drug Administration (USFDA) - BioResearch Monitoring Program (BIMO) Conducted Two Inspections at Veeda CR - Ahmedabad

Veeda CR is glad to share the successful completion of 2 USFDA Inspections at two of its locations at Ahmedabad in Sep-2017. Both the Inspections were Routine Inspections by BIMO (BioResearch ...